nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—skin cancer	0.752	1	CbGaD
Salicylate-sodium—PTGS2—leg—skin cancer	0.0047	0.128	CbGeAlD
Salicylate-sodium—PTGS2—hindlimb—skin cancer	0.0042	0.114	CbGeAlD
Salicylate-sodium—PTGS2—appendage—skin cancer	0.0036	0.0979	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—TP53—skin cancer	0.00301	0.464	CrCbGaD
Salicylate-sodium—PTGS2—skin epidermis—skin cancer	0.003	0.0814	CbGeAlD
Salicylate-sodium—PTGS1—endothelium—skin cancer	0.00228	0.0618	CbGeAlD
Salicylate-sodium—PTGS2—endothelium—skin cancer	0.00218	0.0591	CbGeAlD
Salicylate-sodium—PTGS1—blood vessel—skin cancer	0.0021	0.057	CbGeAlD
Salicylate-sodium—PTGS2—blood vessel—skin cancer	0.00201	0.0545	CbGeAlD
Salicylate-sodium—PTGS1—nipple—skin cancer	0.00152	0.0412	CbGeAlD
Salicylate-sodium—PTGS1—connective tissue—skin cancer	0.00108	0.0292	CbGeAlD
Salicylate-sodium—PTGS2—connective tissue—skin cancer	0.00103	0.0279	CbGeAlD
Salicylate-sodium—PTGS1—epithelium—skin cancer	0.00102	0.0278	CbGeAlD
Salicylate-sodium—PTGS2—epithelium—skin cancer	0.000976	0.0265	CbGeAlD
Salicylate-sodium—PTGS1—skin of body—skin cancer	0.000972	0.0264	CbGeAlD
Salicylate-sodium—PTGS2—skin of body—skin cancer	0.000929	0.0252	CbGeAlD
Salicylate-sodium—Magnesium salicylate—PTGS2—skin cancer	0.000928	0.143	CrCbGaD
Salicylate-sodium—PTGS1—mammalian vulva—skin cancer	0.000886	0.0241	CbGeAlD
Salicylate-sodium—Salsalate—PTGS2—skin cancer	0.000789	0.122	CrCbGaD
Salicylate-sodium—PTGS1—female reproductive system—skin cancer	0.000759	0.0206	CbGeAlD
Salicylate-sodium—PTGS2—lymphoid tissue—skin cancer	0.000752	0.0204	CbGeAlD
Salicylate-sodium—PTGS2—female reproductive system—skin cancer	0.000725	0.0197	CbGeAlD
Salicylate-sodium—Mesalazine—PTGS2—skin cancer	0.000684	0.105	CrCbGaD
Salicylate-sodium—Disorientation—Fluorouracil—skin cancer	0.000682	0.00333	CcSEcCtD
Salicylate-sodium—Bronchospasm—Bleomycin—skin cancer	0.000667	0.00326	CcSEcCtD
Salicylate-sodium—Erythema—Imiquimod—skin cancer	0.000665	0.00325	CcSEcCtD
Salicylate-sodium—Oliguria—Docetaxel—skin cancer	0.000658	0.00322	CcSEcCtD
Salicylate-sodium—Vomiting—Vismodegib—skin cancer	0.000655	0.0032	CcSEcCtD
Salicylate-sodium—Rash—Vismodegib—skin cancer	0.00065	0.00318	CcSEcCtD
Salicylate-sodium—Dermatitis—Vismodegib—skin cancer	0.000649	0.00317	CcSEcCtD
Salicylate-sodium—Hearing impaired—Docetaxel—skin cancer	0.000637	0.00311	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Vemurafenib—skin cancer	0.000637	0.00311	CcSEcCtD
Salicylate-sodium—PTGS1—head—skin cancer	0.000634	0.0172	CbGeAlD
Salicylate-sodium—Dysphagia—Dactinomycin—skin cancer	0.000633	0.00309	CcSEcCtD
Salicylate-sodium—Infection—Vemurafenib—skin cancer	0.000632	0.00309	CcSEcCtD
Salicylate-sodium—Lethargy—Fluorouracil—skin cancer	0.000622	0.00304	CcSEcCtD
Salicylate-sodium—Dehydration—Temozolomide—skin cancer	0.000616	0.00301	CcSEcCtD
Salicylate-sodium—Nausea—Vismodegib—skin cancer	0.000612	0.00299	CcSEcCtD
Salicylate-sodium—PTGS2—head—skin cancer	0.000606	0.0165	CbGeAlD
Salicylate-sodium—Hypokalaemia—Temozolomide—skin cancer	0.000602	0.00294	CcSEcCtD
Salicylate-sodium—Syncope—Imiquimod—skin cancer	0.000597	0.00292	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Bleomycin—skin cancer	0.000596	0.00291	CcSEcCtD
Salicylate-sodium—Hypotension—Vemurafenib—skin cancer	0.000595	0.00291	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Bleomycin—skin cancer	0.000593	0.0029	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—skin cancer	0.000589	0.0908	CrCbGaD
Salicylate-sodium—Palpitations—Imiquimod—skin cancer	0.000588	0.00287	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Imiquimod—skin cancer	0.000585	0.00286	CcSEcCtD
Salicylate-sodium—Irritability—Fluorouracil—skin cancer	0.000582	0.00285	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Docetaxel—skin cancer	0.000579	0.00283	CcSEcCtD
Salicylate-sodium—Convulsion—Imiquimod—skin cancer	0.000576	0.00282	CcSEcCtD
Salicylate-sodium—Abdominal distension—Temozolomide—skin cancer	0.000576	0.00282	CcSEcCtD
Salicylate-sodium—Fluid retention—Docetaxel—skin cancer	0.000576	0.00281	CcSEcCtD
Salicylate-sodium—Dysphagia—Temozolomide—skin cancer	0.000572	0.0028	CcSEcCtD
Salicylate-sodium—Chest pain—Imiquimod—skin cancer	0.000566	0.00277	CcSEcCtD
Salicylate-sodium—Anxiety—Imiquimod—skin cancer	0.000564	0.00276	CcSEcCtD
Salicylate-sodium—Sweating increased—Temozolomide—skin cancer	0.000557	0.00272	CcSEcCtD
Salicylate-sodium—Oesophagitis—Docetaxel—skin cancer	0.000554	0.00271	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vemurafenib—skin cancer	0.000553	0.0027	CcSEcCtD
Salicylate-sodium—Bronchitis—Temozolomide—skin cancer	0.00055	0.00269	CcSEcCtD
Salicylate-sodium—Fatigue—Vemurafenib—skin cancer	0.000549	0.00268	CcSEcCtD
Salicylate-sodium—Constipation—Vemurafenib—skin cancer	0.000544	0.00266	CcSEcCtD
Salicylate-sodium—Oedema—Imiquimod—skin cancer	0.000543	0.00265	CcSEcCtD
Salicylate-sodium—Lightheadedness—Docetaxel—skin cancer	0.000543	0.00265	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Bleomycin—skin cancer	0.00054	0.00264	CcSEcCtD
Salicylate-sodium—Infection—Imiquimod—skin cancer	0.000539	0.00264	CcSEcCtD
Salicylate-sodium—Shock—Imiquimod—skin cancer	0.000534	0.00261	CcSEcCtD
Salicylate-sodium—Tachycardia—Imiquimod—skin cancer	0.00053	0.00259	CcSEcCtD
Salicylate-sodium—Dysphagia—Fluorouracil—skin cancer	0.000527	0.00258	CcSEcCtD
Salicylate-sodium—Sepsis—Docetaxel—skin cancer	0.000526	0.00257	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Imiquimod—skin cancer	0.000525	0.00257	CcSEcCtD
Salicylate-sodium—Weight increased—Temozolomide—skin cancer	0.000521	0.00254	CcSEcCtD
Salicylate-sodium—Anorexia—Imiquimod—skin cancer	0.000517	0.00253	CcSEcCtD
Salicylate-sodium—Phlebitis—Docetaxel—skin cancer	0.000511	0.0025	CcSEcCtD
Salicylate-sodium—Hepatitis—Dactinomycin—skin cancer	0.000506	0.00247	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vemurafenib—skin cancer	0.000503	0.00246	CcSEcCtD
Salicylate-sodium—Swelling—Docetaxel—skin cancer	0.000499	0.00244	CcSEcCtD
Salicylate-sodium—Deafness—Docetaxel—skin cancer	0.000492	0.00241	CcSEcCtD
Salicylate-sodium—Paraesthesia—Imiquimod—skin cancer	0.000487	0.00238	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Docetaxel—skin cancer	0.000485	0.00237	CcSEcCtD
Salicylate-sodium—Salicylic acid—PTGS2—skin cancer	0.000485	0.0748	CrCbGaD
Salicylate-sodium—Dyspnoea—Imiquimod—skin cancer	0.000484	0.00237	CcSEcCtD
Salicylate-sodium—Somnolence—Imiquimod—skin cancer	0.000483	0.00236	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Dactinomycin—skin cancer	0.000479	0.00234	CcSEcCtD
Salicylate-sodium—Dyspepsia—Imiquimod—skin cancer	0.000478	0.00234	CcSEcCtD
Salicylate-sodium—Erythema—Bleomycin—skin cancer	0.000473	0.00231	CcSEcCtD
Salicylate-sodium—Decreased appetite—Imiquimod—skin cancer	0.000472	0.00231	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vemurafenib—skin cancer	0.000469	0.00229	CcSEcCtD
Salicylate-sodium—Fatigue—Imiquimod—skin cancer	0.000468	0.00229	CcSEcCtD
Salicylate-sodium—Pain—Imiquimod—skin cancer	0.000464	0.00227	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Fluorouracil—skin cancer	0.000463	0.00226	CcSEcCtD
Salicylate-sodium—Renal impairment—Docetaxel—skin cancer	0.000463	0.00226	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Fluorouracil—skin cancer	0.000461	0.00225	CcSEcCtD
Salicylate-sodium—Hepatitis—Temozolomide—skin cancer	0.000458	0.00224	CcSEcCtD
Salicylate-sodium—Asthenia—Vemurafenib—skin cancer	0.000457	0.00223	CcSEcCtD
Salicylate-sodium—Hallucination—Temozolomide—skin cancer	0.000456	0.00223	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Temozolomide—skin cancer	0.000456	0.00223	CcSEcCtD
Salicylate-sodium—Pruritus—Vemurafenib—skin cancer	0.00045	0.0022	CcSEcCtD
Salicylate-sodium—Lethargy—Docetaxel—skin cancer	0.000449	0.0022	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Imiquimod—skin cancer	0.000447	0.00219	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Imiquimod—skin cancer	0.000444	0.00217	CcSEcCtD
Salicylate-sodium—PTGS1—lymph node—skin cancer	0.000444	0.0121	CbGeAlD
Salicylate-sodium—Epistaxis—Fluorouracil—skin cancer	0.000443	0.00217	CcSEcCtD
Salicylate-sodium—Erythema—Dactinomycin—skin cancer	0.000441	0.00215	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vemurafenib—skin cancer	0.000436	0.00213	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Temozolomide—skin cancer	0.000433	0.00212	CcSEcCtD
Salicylate-sodium—Urticaria—Imiquimod—skin cancer	0.000431	0.00211	CcSEcCtD
Salicylate-sodium—Body temperature increased—Imiquimod—skin cancer	0.000429	0.0021	CcSEcCtD
Salicylate-sodium—Abdominal pain—Imiquimod—skin cancer	0.000429	0.0021	CcSEcCtD
Salicylate-sodium—Tinnitus—Temozolomide—skin cancer	0.000427	0.00209	CcSEcCtD
Salicylate-sodium—PTGS2—lymph node—skin cancer	0.000424	0.0115	CbGeAlD
Salicylate-sodium—Dizziness—Vemurafenib—skin cancer	0.000421	0.00206	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Fluorouracil—skin cancer	0.00042	0.00205	CcSEcCtD
Salicylate-sodium—Dehydration—Docetaxel—skin cancer	0.000409	0.002	CcSEcCtD
Salicylate-sodium—Vomiting—Vemurafenib—skin cancer	0.000405	0.00198	CcSEcCtD
Salicylate-sodium—Chest pain—Bleomycin—skin cancer	0.000402	0.00197	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Docetaxel—skin cancer	0.000402	0.00197	CcSEcCtD
Salicylate-sodium—Rash—Vemurafenib—skin cancer	0.000401	0.00196	CcSEcCtD
Salicylate-sodium—Dermatitis—Vemurafenib—skin cancer	0.000401	0.00196	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Imiquimod—skin cancer	0.0004	0.00196	CcSEcCtD
Salicylate-sodium—Headache—Vemurafenib—skin cancer	0.000399	0.00195	CcSEcCtD
Salicylate-sodium—Erythema—Temozolomide—skin cancer	0.000399	0.00195	CcSEcCtD
Salicylate-sodium—Dysgeusia—Temozolomide—skin cancer	0.00039	0.00191	CcSEcCtD
Salicylate-sodium—Asthenia—Imiquimod—skin cancer	0.00039	0.0019	CcSEcCtD
Salicylate-sodium—Confusional state—Bleomycin—skin cancer	0.000389	0.0019	CcSEcCtD
Salicylate-sodium—Oedema—Bleomycin—skin cancer	0.000386	0.00189	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Bleomycin—skin cancer	0.000386	0.00189	CcSEcCtD
Salicylate-sodium—Pruritus—Imiquimod—skin cancer	0.000384	0.00188	CcSEcCtD
Salicylate-sodium—Infection—Bleomycin—skin cancer	0.000383	0.00187	CcSEcCtD
Salicylate-sodium—Dysphagia—Docetaxel—skin cancer	0.00038	0.00186	CcSEcCtD
Salicylate-sodium—Nausea—Vemurafenib—skin cancer	0.000378	0.00185	CcSEcCtD
Salicylate-sodium—Arrhythmia—Fluorouracil—skin cancer	0.000377	0.00184	CcSEcCtD
Salicylate-sodium—Vision blurred—Temozolomide—skin cancer	0.000376	0.00184	CcSEcCtD
Salicylate-sodium—Bronchospasm—Docetaxel—skin cancer	0.000374	0.00183	CcSEcCtD
Salicylate-sodium—Diarrhoea—Imiquimod—skin cancer	0.000371	0.00182	CcSEcCtD
Salicylate-sodium—Anorexia—Bleomycin—skin cancer	0.000368	0.0018	CcSEcCtD
Salicylate-sodium—Erythema—Fluorouracil—skin cancer	0.000367	0.0018	CcSEcCtD
Salicylate-sodium—Hypotension—Bleomycin—skin cancer	0.00036	0.00176	CcSEcCtD
Salicylate-sodium—Oedema—Dactinomycin—skin cancer	0.00036	0.00176	CcSEcCtD
Salicylate-sodium—Dizziness—Imiquimod—skin cancer	0.000359	0.00175	CcSEcCtD
Salicylate-sodium—Infection—Dactinomycin—skin cancer	0.000357	0.00175	CcSEcCtD
Salicylate-sodium—Palpitations—Temozolomide—skin cancer	0.000352	0.00172	CcSEcCtD
Salicylate-sodium—Paraesthesia—Bleomycin—skin cancer	0.000346	0.00169	CcSEcCtD
Salicylate-sodium—Weight increased—Docetaxel—skin cancer	0.000346	0.00169	CcSEcCtD
Salicylate-sodium—Vision blurred—Fluorouracil—skin cancer	0.000346	0.00169	CcSEcCtD
Salicylate-sodium—Convulsion—Temozolomide—skin cancer	0.000345	0.00169	CcSEcCtD
Salicylate-sodium—Vomiting—Imiquimod—skin cancer	0.000345	0.00169	CcSEcCtD
Salicylate-sodium—Dyspnoea—Bleomycin—skin cancer	0.000344	0.00168	CcSEcCtD
Salicylate-sodium—Anorexia—Dactinomycin—skin cancer	0.000343	0.00168	CcSEcCtD
Salicylate-sodium—Rash—Imiquimod—skin cancer	0.000342	0.00167	CcSEcCtD
Salicylate-sodium—Dermatitis—Imiquimod—skin cancer	0.000342	0.00167	CcSEcCtD
Salicylate-sodium—Headache—Imiquimod—skin cancer	0.00034	0.00166	CcSEcCtD
Salicylate-sodium—Anxiety—Temozolomide—skin cancer	0.000338	0.00165	CcSEcCtD
Salicylate-sodium—Decreased appetite—Bleomycin—skin cancer	0.000335	0.00164	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Docetaxel—skin cancer	0.000334	0.00163	CcSEcCtD
Salicylate-sodium—Renal failure—Docetaxel—skin cancer	0.000333	0.00163	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Docetaxel—skin cancer	0.000333	0.00163	CcSEcCtD
Salicylate-sodium—Pain—Bleomycin—skin cancer	0.00033	0.00161	CcSEcCtD
Salicylate-sodium—Confusional state—Temozolomide—skin cancer	0.000328	0.0016	CcSEcCtD
Salicylate-sodium—Oedema—Temozolomide—skin cancer	0.000325	0.00159	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Temozolomide—skin cancer	0.000325	0.00159	CcSEcCtD
Salicylate-sodium—Infection—Temozolomide—skin cancer	0.000323	0.00158	CcSEcCtD
Salicylate-sodium—Nausea—Imiquimod—skin cancer	0.000322	0.00158	CcSEcCtD
Salicylate-sodium—Epistaxis—Docetaxel—skin cancer	0.00032	0.00156	CcSEcCtD
Salicylate-sodium—Convulsion—Fluorouracil—skin cancer	0.000318	0.00156	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Bleomycin—skin cancer	0.000318	0.00155	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Temozolomide—skin cancer	0.000315	0.00154	CcSEcCtD
Salicylate-sodium—Chest pain—Fluorouracil—skin cancer	0.000313	0.00153	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dactinomycin—skin cancer	0.000313	0.00153	CcSEcCtD
Salicylate-sodium—Fatigue—Dactinomycin—skin cancer	0.00031	0.00152	CcSEcCtD
Salicylate-sodium—Anorexia—Temozolomide—skin cancer	0.00031	0.00152	CcSEcCtD
Salicylate-sodium—Pain—Dactinomycin—skin cancer	0.000308	0.0015	CcSEcCtD
Salicylate-sodium—Urticaria—Bleomycin—skin cancer	0.000306	0.0015	CcSEcCtD
Salicylate-sodium—Body temperature increased—Bleomycin—skin cancer	0.000305	0.00149	CcSEcCtD
Salicylate-sodium—Hepatitis—Docetaxel—skin cancer	0.000305	0.00149	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Docetaxel—skin cancer	0.000303	0.00148	CcSEcCtD
Salicylate-sodium—Confusional state—Fluorouracil—skin cancer	0.000302	0.00148	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Fluorouracil—skin cancer	0.0003	0.00147	CcSEcCtD
Salicylate-sodium—Oedema—Fluorouracil—skin cancer	0.0003	0.00147	CcSEcCtD
Salicylate-sodium—Infection—Fluorouracil—skin cancer	0.000298	0.00146	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dactinomycin—skin cancer	0.000296	0.00145	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dactinomycin—skin cancer	0.000294	0.00144	CcSEcCtD
Salicylate-sodium—Tachycardia—Fluorouracil—skin cancer	0.000293	0.00143	CcSEcCtD
Salicylate-sodium—Paraesthesia—Temozolomide—skin cancer	0.000292	0.00143	CcSEcCtD
Salicylate-sodium—Dyspnoea—Temozolomide—skin cancer	0.00029	0.00142	CcSEcCtD
Salicylate-sodium—Somnolence—Temozolomide—skin cancer	0.000289	0.00141	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Docetaxel—skin cancer	0.000288	0.00141	CcSEcCtD
Salicylate-sodium—Dyspepsia—Temozolomide—skin cancer	0.000286	0.0014	CcSEcCtD
Salicylate-sodium—Anorexia—Fluorouracil—skin cancer	0.000286	0.0014	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dactinomycin—skin cancer	0.000284	0.00139	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dactinomycin—skin cancer	0.000284	0.00139	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Bleomycin—skin cancer	0.000284	0.00139	CcSEcCtD
Salicylate-sodium—Decreased appetite—Temozolomide—skin cancer	0.000283	0.00138	CcSEcCtD
Salicylate-sodium—Fatigue—Temozolomide—skin cancer	0.00028	0.00137	CcSEcCtD
Salicylate-sodium—Hypotension—Fluorouracil—skin cancer	0.00028	0.00137	CcSEcCtD
Salicylate-sodium—Pain—Temozolomide—skin cancer	0.000278	0.00136	CcSEcCtD
Salicylate-sodium—Constipation—Temozolomide—skin cancer	0.000278	0.00136	CcSEcCtD
Salicylate-sodium—Asthenia—Bleomycin—skin cancer	0.000277	0.00135	CcSEcCtD
Salicylate-sodium—Pruritus—Bleomycin—skin cancer	0.000273	0.00133	CcSEcCtD
Salicylate-sodium—Arrhythmia—Docetaxel—skin cancer	0.000272	0.00133	CcSEcCtD
Salicylate-sodium—Paraesthesia—Fluorouracil—skin cancer	0.000269	0.00132	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Temozolomide—skin cancer	0.000268	0.00131	CcSEcCtD
Salicylate-sodium—Dyspnoea—Fluorouracil—skin cancer	0.000267	0.00131	CcSEcCtD
Salicylate-sodium—Somnolence—Fluorouracil—skin cancer	0.000266	0.0013	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Temozolomide—skin cancer	0.000266	0.0013	CcSEcCtD
Salicylate-sodium—Erythema—Docetaxel—skin cancer	0.000265	0.0013	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dactinomycin—skin cancer	0.000265	0.0013	CcSEcCtD
Salicylate-sodium—Dyspepsia—Fluorouracil—skin cancer	0.000264	0.00129	CcSEcCtD
Salicylate-sodium—Decreased appetite—Fluorouracil—skin cancer	0.000261	0.00127	CcSEcCtD
Salicylate-sodium—Dysgeusia—Docetaxel—skin cancer	0.00026	0.00127	CcSEcCtD
Salicylate-sodium—Urticaria—Temozolomide—skin cancer	0.000258	0.00126	CcSEcCtD
Salicylate-sodium—Asthenia—Dactinomycin—skin cancer	0.000258	0.00126	CcSEcCtD
Salicylate-sodium—Abdominal pain—Temozolomide—skin cancer	0.000257	0.00126	CcSEcCtD
Salicylate-sodium—Body temperature increased—Temozolomide—skin cancer	0.000257	0.00126	CcSEcCtD
Salicylate-sodium—Pain—Fluorouracil—skin cancer	0.000256	0.00125	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Fluorouracil—skin cancer	0.000247	0.00121	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dactinomycin—skin cancer	0.000246	0.0012	CcSEcCtD
Salicylate-sodium—Vomiting—Bleomycin—skin cancer	0.000245	0.0012	CcSEcCtD
Salicylate-sodium—Rash—Bleomycin—skin cancer	0.000243	0.00119	CcSEcCtD
Salicylate-sodium—Dermatitis—Bleomycin—skin cancer	0.000243	0.00119	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Temozolomide—skin cancer	0.00024	0.00117	CcSEcCtD
Salicylate-sodium—Urticaria—Fluorouracil—skin cancer	0.000238	0.00116	CcSEcCtD
Salicylate-sodium—Syncope—Docetaxel—skin cancer	0.000238	0.00116	CcSEcCtD
Salicylate-sodium—Body temperature increased—Fluorouracil—skin cancer	0.000237	0.00116	CcSEcCtD
Salicylate-sodium—Palpitations—Docetaxel—skin cancer	0.000234	0.00115	CcSEcCtD
Salicylate-sodium—Asthenia—Temozolomide—skin cancer	0.000233	0.00114	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Docetaxel—skin cancer	0.000233	0.00114	CcSEcCtD
Salicylate-sodium—Pruritus—Temozolomide—skin cancer	0.00023	0.00113	CcSEcCtD
Salicylate-sodium—Convulsion—Docetaxel—skin cancer	0.00023	0.00112	CcSEcCtD
Salicylate-sodium—Nausea—Bleomycin—skin cancer	0.000229	0.00112	CcSEcCtD
Salicylate-sodium—Vomiting—Dactinomycin—skin cancer	0.000229	0.00112	CcSEcCtD
Salicylate-sodium—Rash—Dactinomycin—skin cancer	0.000227	0.00111	CcSEcCtD
Salicylate-sodium—Chest pain—Docetaxel—skin cancer	0.000226	0.0011	CcSEcCtD
Salicylate-sodium—Diarrhoea—Temozolomide—skin cancer	0.000223	0.00109	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Fluorouracil—skin cancer	0.000221	0.00108	CcSEcCtD
Salicylate-sodium—Confusional state—Docetaxel—skin cancer	0.000218	0.00107	CcSEcCtD
Salicylate-sodium—Oedema—Docetaxel—skin cancer	0.000216	0.00106	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Docetaxel—skin cancer	0.000216	0.00106	CcSEcCtD
Salicylate-sodium—Dizziness—Temozolomide—skin cancer	0.000215	0.00105	CcSEcCtD
Salicylate-sodium—Infection—Docetaxel—skin cancer	0.000215	0.00105	CcSEcCtD
Salicylate-sodium—Nausea—Dactinomycin—skin cancer	0.000214	0.00104	CcSEcCtD
Salicylate-sodium—Shock—Docetaxel—skin cancer	0.000213	0.00104	CcSEcCtD
Salicylate-sodium—Pruritus—Fluorouracil—skin cancer	0.000212	0.00104	CcSEcCtD
Salicylate-sodium—Tachycardia—Docetaxel—skin cancer	0.000211	0.00103	CcSEcCtD
Salicylate-sodium—Vomiting—Temozolomide—skin cancer	0.000207	0.00101	CcSEcCtD
Salicylate-sodium—Anorexia—Docetaxel—skin cancer	0.000206	0.00101	CcSEcCtD
Salicylate-sodium—Rash—Temozolomide—skin cancer	0.000205	0.001	CcSEcCtD
Salicylate-sodium—Diarrhoea—Fluorouracil—skin cancer	0.000205	0.001	CcSEcCtD
Salicylate-sodium—Dermatitis—Temozolomide—skin cancer	0.000205	0.001	CcSEcCtD
Salicylate-sodium—Headache—Temozolomide—skin cancer	0.000204	0.000996	CcSEcCtD
Salicylate-sodium—Hypotension—Docetaxel—skin cancer	0.000202	0.000988	CcSEcCtD
Salicylate-sodium—Dizziness—Fluorouracil—skin cancer	0.000198	0.000969	CcSEcCtD
Salicylate-sodium—Paraesthesia—Docetaxel—skin cancer	0.000194	0.00095	CcSEcCtD
Salicylate-sodium—Nausea—Temozolomide—skin cancer	0.000193	0.000945	CcSEcCtD
Salicylate-sodium—Dyspnoea—Docetaxel—skin cancer	0.000193	0.000943	CcSEcCtD
Salicylate-sodium—Somnolence—Docetaxel—skin cancer	0.000192	0.00094	CcSEcCtD
Salicylate-sodium—Vomiting—Fluorouracil—skin cancer	0.000191	0.000932	CcSEcCtD
Salicylate-sodium—Dyspepsia—Docetaxel—skin cancer	0.00019	0.000931	CcSEcCtD
Salicylate-sodium—Rash—Fluorouracil—skin cancer	0.000189	0.000924	CcSEcCtD
Salicylate-sodium—Dermatitis—Fluorouracil—skin cancer	0.000189	0.000923	CcSEcCtD
Salicylate-sodium—Decreased appetite—Docetaxel—skin cancer	0.000188	0.000919	CcSEcCtD
Salicylate-sodium—Headache—Fluorouracil—skin cancer	0.000188	0.000918	CcSEcCtD
Salicylate-sodium—Fatigue—Docetaxel—skin cancer	0.000187	0.000912	CcSEcCtD
Salicylate-sodium—Constipation—Docetaxel—skin cancer	0.000185	0.000904	CcSEcCtD
Salicylate-sodium—Pain—Docetaxel—skin cancer	0.000185	0.000904	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Docetaxel—skin cancer	0.000178	0.000871	CcSEcCtD
Salicylate-sodium—Nausea—Fluorouracil—skin cancer	0.000178	0.00087	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Docetaxel—skin cancer	0.000177	0.000865	CcSEcCtD
Salicylate-sodium—Abdominal pain—Docetaxel—skin cancer	0.000171	0.000836	CcSEcCtD
Salicylate-sodium—Body temperature increased—Docetaxel—skin cancer	0.000171	0.000836	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Docetaxel—skin cancer	0.000159	0.000779	CcSEcCtD
Salicylate-sodium—Asthenia—Docetaxel—skin cancer	0.000155	0.000759	CcSEcCtD
Salicylate-sodium—Pruritus—Docetaxel—skin cancer	0.000153	0.000748	CcSEcCtD
Salicylate-sodium—Diarrhoea—Docetaxel—skin cancer	0.000148	0.000724	CcSEcCtD
Salicylate-sodium—Dizziness—Docetaxel—skin cancer	0.000143	0.000699	CcSEcCtD
Salicylate-sodium—Vomiting—Docetaxel—skin cancer	0.000138	0.000672	CcSEcCtD
Salicylate-sodium—Rash—Docetaxel—skin cancer	0.000136	0.000667	CcSEcCtD
Salicylate-sodium—Dermatitis—Docetaxel—skin cancer	0.000136	0.000666	CcSEcCtD
Salicylate-sodium—Headache—Docetaxel—skin cancer	0.000136	0.000663	CcSEcCtD
Salicylate-sodium—Nausea—Docetaxel—skin cancer	0.000129	0.000628	CcSEcCtD
